Skip to content

ERAS and Pediatric Scoliosis Surgery

Assesment of Enhanced Recovery After Pediatric Idiopathic Scoliosis Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04012528
Acronym
RAAC
Enrollment
150
Registered
2019-07-09
Start date
2018-01-01
Completion date
2021-11-30
Last updated
2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis

Keywords

Pediatric, Surgery, Rehabilitation

Brief summary

The aim of this study is to compare the outcomes after scoliosis surgery before and after ERAS (enhanced recovery after surgery) program inplementation in children and teenager.

Detailed description

Enhanced recovery after surgery (ERAS) is a multimodal approach focused on reducing the stress response and associated physiologic changes related to surgery. Over the past 20 years, ERAS programs have been found to result in reduced lenght of stay and complications in adult patients. Data in pediatric population remains very scarce.Therefore this study was designed to compare the outcomes after scoliosis surgery before and after ERAS (enhanced recovery after surgery) program inplementation in children and teenager.

Interventions

ERAS program

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* patient with age \< 18 years * patient scheduled for scoliosis surgery

Exclusion criteria

* patient with age \> 18years * patient with medical follow up by pediatric chronic pain departement

Design outcomes

Primary

MeasureTime frameDescription
Postoperative length of hospital stayup to 4 weeks after surgeryPostoperative length of hospital stay

Secondary

MeasureTime frameDescription
Number of Antalgics consumptionup to 15 days after surgeryAntalgics consumption including opioids and non-opioids drug
Time to oral diet toleranceup to 15 days after surgeryAble to eat without abdominal discomfort, nausea, or vomiting
Time to first bowel motionup to 15 days after surgeryAble to eat without abdominal discomfort, nausea, or vomiting
Time to first verticalizationup to 15 days after surgeryAble to eat without abdominal discomfort, nausea, or vomiting

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026